Abstract
Purpose
This study was designed to optimize the flip angle (FA) and scan timing of the hepatobiliary phase (HBP) using the 3D T1-weighted, gradient-echo (GRE) imaging with controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) technique on gadoxetic acid-enhanced 3T liver MR imaging.
Materials and Methods
Sixty-two patients who underwent gadoxetic acid-enhanced 3T liver MR imaging were included in this study. Four 3D T1-weighted GRE imaging studies using the CAIPIRINHA technique and FAs of 9° and 13° were acquired during HBP at 15 and 20 min after intravenous injection of gadoxetic acid. Two abdominal radiologists, who were blinded to the FA and the timing of image acquisition, assessed the sharpness of liver edge, hepatic vessel clarity, lesion conspicuity, artifact severity, and overall image quality using a five-point scale. Quantitative analysis was performed by another radiologist to estimate the relative liver enhancement (RLE) and the signal-to-noise ratio (SNR). Statistical analyses were performed using the Wilcoxon signed rank test and one-way analysis of variance.
Results
The scores of the HBP with an FA of 13° during the same delayed time were significantly higher than those of the HBP with an FA of 9° in all the assessment items (P < 0.01). In terms of the delay time, images at the same FA obtained with a 20-min-HBP showed better quality than those obtained with a 15-min-HBP. There was no significant difference in qualitative scores between the 20-min-HBP and the 15-min-HBP images in the non-liver cirrhosis (LC) group except for the hepatic vessel clarity score with 9° FA. In the quantitative analysis, a statistically significant difference was found in the degree of RLE in the four HBP images (P = 0.012). However, in the subgroup analysis, no significant difference in RLE was found in the four HBP images in either the LC or the non-LC groups. The SNR did not differ significantly in the four HBP images. In the subgroup analysis, 20-min-HBP imaging with a 13° FA showed the highest SNR value in the LC-group, whereas 15-min-HBP imaging with a 13° FA showed the best value of SNR in the non-LC group.
Conclusion
The use of a moderately high FA improves the image quality and lesion conspicuity on 3D, T1-weighted GRE imaging using the CAIPIRINHA technique on gadoxetic acid, 3T liver MR imaging. In patients with normal liver function, the 15-min-HBP with a 13° FA represents a feasible option without a significant decrease in image quality.
References
1. Kim BS, Angthong W, Jeon YH, Semelka RC. Body MR imaging: fast, efficient, and comprehensive. Radiol Clin North Am. 2014; 52:623–636.
2. Semelka RC, Martin DR, Balci NC. Magnetic resonance imaging of the liver: how I do it. J Gastroenterol Hepatol. 2006; 21:632–637.
3. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001; 218:27–38.
4. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breathhold examination. Radiology. 1999; 212:876–884.
5. Yu MH, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI. Clinical application of controlled aliasing in parallel imaging results in a higher acceleration (CAIPIRINHA)volumetric interpolated breathhold (VIBE) sequence for gadoxetic acid-enhanced liver MR imaging. J Magn Reson Imaging. 2013; 38:1020–1026.
6. Kim BS, Lee KR, Goh MJ. New imaging strategies using a motion-resistant liver sequence in uncooperative patients. Biomed Res Int. 2014; 2014:142658.
7. Wright KL, Harrell MW, Jesberger JA, et al. Clinical evaluation of CAIPIRINHA: comparison against a GRAPPA standard. J Magn Reson Imaging. 2014; 39:189–194.
8. Park YS, Lee CH, Kim IS, et al. Usefulness of controlled aliasing in parallel imaging results in higher acceleration in gadoxetic acid-enhanced liver magnetic resonance imaging to clarify the hepatic arterial phase. Invest Radiol. 2014; 49:183–188.
9. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 2004; 230:266–275.
10. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009; 29:1725–1748.
11. Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics. 2011; 31:1547–1568.
12. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K. Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol. 2011; 21:2336–2343.
13. Motosugi U, Ichikawa T, Tominaga L, et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol. 2009; 19:2623–2629.
14. Haradome H, Grazioli L, Al manea K, et al. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging. 2012; 35:132–139.
15. Bashir MR, Husarik DB, Ziemlewicz TJ, Gupta RT, Boll DT, Merkle EM. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? J Magn Reson Imaging. 2012; 35:611–616.
16. Bashir MR, Merkle EM. Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol. 2011; 21:291–294.
17. Cho ES, Yu JS, Park AY, Woo S, Kim JH, Chung JJ. Feasibility of 5-minute delayed transition phase imaging with 30 degrees flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10 degrees flip angle. AJR Am J Roentgenol. 2015; 204:69–75.
18. Chang KJ, Kamel IR, Macura KJ, Bluemke DA. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008; 28:1983–1998.
19. Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR. Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics. 2009; 29:1547–1563.
20. Kim S, Mussi TC, Lee LJ, Mausner EV, Cho KC, Rosenkrantz AB. Effect of flip angle for optimization of image quality of gadoxetate disodium-enhanced biliary imaging at 1.5 T. AJR Am J Roentgenol. 2013; 200:90–96.
21. Bashir MR, Breault SR, Braun R, Do RK, Nelson RC, Reeder SB. Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI. Acad Radiol. 2014; 21:726–732.
22. van Kessel CS, Veldhuis WB, van den Bosch MA, van Leeuwen MS. MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation. Eur Radiol. 2012; 22:2153–2160.
23. Kim SH, Kim SH, Lee J, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2009; 192:1675–1681.
Table 1.
Quality parameter | Flip angle and delayed time | P value | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Same flip angle | Same delayed time | Different flip angle and delayed time | ||||||||
20 min 13° | 15 min 13° | 20 min 9° | 15 min 9° | 20 min 13° vs. 15 min 13° | 20 min 9° vs. 15 min 9° | 20 min 13° vs. 20 min 9° | 15 min 13° vs. 15 min 9° | 15 min 13° vs. 20 min 9° | 20 min 13° vs. 13 min 9° | |
Liver edge sharpness | ||||||||||
Total | 4.77 | 4.69 | 4.63 | 4.54 | 0.083 | 0.047* | 0.001* | 0.001* | 0.288 | 0.000* |
LC | 4.76 | 4.64 | 4.55 | 4.47 | 0.021* | 0.084 | 0.011* | 0.001* | 0.185 | 0.000* |
Non-LC | 4.78 | 4.76 | 4.76 | 4.64 | 0.854 | 0.236 | 0.034* | 0.564 | 1.000 | 0.272 |
Hepatic vessel clarity | ||||||||||
Total | 4.50 | 4.33 | 4.07 | 3.88 | 0.001* | 0.004* | 0.000* | 0.000* | 0.001* | 0.000* |
LC | 4.43 | 4.24 | 3.93 | 3.80 | 0.003* | 0.04* | 0.000* | 0.000* | 0.005* | 0.000* |
Non-LC | 4.62 | 4.46 | 4.28 | 4.00 | 0.143 | 0.04* | 0.000* | 0.002* | 0.103* | 0.001* |
Lesion conspicuity | ||||||||||
Total | 4.73 | 4.58 | 4.26 | 4.13 | 0.003* | 0.008* | 0.000* | 0.000* | 0.000* | 0.000* |
LC | 4.64 | 4.42 | 4.08 | 3.96 | 0.005* | 0.034* | 0.000* | 0.000* | 0.003* | 0.000* |
Non-LC | 4.92 | 4.89 | 4.62 | 4.46 | 0.317 | 0.102 | 0.009* | 0.025* | 0.02* | 0.01* |
Artifact severity | ||||||||||
Total | 4.48 | 4.40 | 4.33 | 4.25 | 0.223 | 0.194 | 0.005* | 0.001* | 0.119 | 0.002* |
LC | 4.42 | 4.32 | 4.22 | 4.21 | 0.257 | 0.655 | 0.06 | 0.004* | 0.057 | 0.005* |
Non-LC | 4.56 | 4.48 | 4.50 | 4.32 | 0.518 | 0.244 | 0.023* | 0.083 | 0.891 | 0.098 |
Overall image quality | ||||||||||
Total | 4.60 | 4.48 | 4.31 | 4.23 | 0.041* | 0.073 | 0.000* | 0.000* | 0.001* | 0.000* |
LC | 4.55 | 4.42 | 4.18 | 4.13 | 0.029* | 0.157 | 0.000* | 0.000* | 0.001* | 0.000* |
Non-LC | 4.66 | 4.58 | 4.50 | 4.38 | 0.51 | 0.236 | 0.004* | 0.011 | 0.219 | 0.024* |
Table 2.
Parameter | Flip angle and delayed time | P value | |||
---|---|---|---|---|---|
20 min 13° | 15 min 13° | 20 min 9° | 15 min 9° | ||
Relative liver enhancement | |||||
Total | 0.9141 ± 0.3751 | 0.8819 ± 0.3454 | 0.7683 ± 0.3006 | 0.7546 ± 0.2782 | 0.012* |
LC | 0.9123 ± 0.3577 | 0.8760 ± 0.3307 | 0.7639 ± 0.9258 | 0.7515 ± 0.2800 | 0.073 |
Non-LC | 0.9168 ± 0.4070 | 0.8906 ± 0.3728 | 0.7748 ± 0.3140 | 0.7593 ± 0.2812 | 0.272 |
SNR of the liver parenchyma | |||||
Total | 251.06 ± 78.62 | 245.51 ± 72.69 | 239.76 ± 28.28 | 239.72 ± 60.89 | 0.757 |
LC | 245.84 ± 86.75 | 232.49 ± 73.48 | 232.41 ± 56.00 | 236.84 ± 67.71 | 0.836 |
Non-LC | 258.79 ± 65.71 | 264.78 ± 68.42 | 250.62 ± 61.01 | 243.98 ± 50.15 | 0.652 |